• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用特征工程和嵌入学习对临床试验终止进行预测建模。

Predictive modeling of clinical trial terminations using feature engineering and embedding learning.

机构信息

Department of Computer & Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL, 33431, USA.

出版信息

Sci Rep. 2021 Feb 10;11(1):3446. doi: 10.1038/s41598-021-82840-x.

DOI:10.1038/s41598-021-82840-x
PMID:33568706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7876037/
Abstract

In this study, we propose to use machine learning to understand terminated clinical trials. Our goal is to answer two fundamental questions: (1) what are common factors/markers associated to terminated clinical trials? and (2) how to accurately predict whether a clinical trial may be terminated or not? The answer to the first question provides effective ways to understand characteristics of terminated trials for stakeholders to better plan their trials; and the answer to the second question can direct estimate the chance of success of a clinical trial in order to minimize costs. By using 311,260 trials to build a testbed with 68,999 samples, we use feature engineering to create 640 features, reflecting clinical trial administration, eligibility, study information, criteria etc. Using feature ranking, a handful of features, such as trial eligibility, trial inclusion/exclusion criteria, sponsor types etc., are found to be related to the clinical trial termination. By using sampling and ensemble learning, we achieve over 67% Balanced Accuracy and over 0.73 AUC (Area Under the Curve) scores to correctly predict clinical trial termination, indicating that machine learning can help achieve satisfactory prediction results for clinical trial study.

摘要

在这项研究中,我们提议使用机器学习来理解已终止的临床试验。我们的目标是回答两个基本问题:(1)与已终止临床试验相关的常见因素/标志物有哪些?(2)如何准确预测一项临床试验是否可能终止?第一个问题的答案为利益相关者提供了了解终止试验特征的有效方法,以便更好地规划他们的试验;第二个问题的答案可以直接估计临床试验成功的机会,以最小化成本。我们使用 311260 项试验构建了一个包含 68999 个样本的测试平台,使用特征工程创建了 640 个特征,反映了临床试验管理、资格、研究信息、标准等。通过特征排名,发现一些特征,如试验资格、试验纳入/排除标准、赞助商类型等,与临床试验终止有关。通过采样和集成学习,我们实现了超过 67%的平衡准确率和超过 0.73 的 AUC(曲线下面积)分数,以正确预测临床试验终止,表明机器学习可以帮助实现对临床试验研究的令人满意的预测结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/5368d63773a9/41598_2021_82840_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/a9803f4f6cec/41598_2021_82840_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/e0870718eacc/41598_2021_82840_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/1e2f5b952f46/41598_2021_82840_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/2578f8f7b917/41598_2021_82840_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/2b383c3d4d6d/41598_2021_82840_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/5368d63773a9/41598_2021_82840_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/a9803f4f6cec/41598_2021_82840_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/e0870718eacc/41598_2021_82840_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/1e2f5b952f46/41598_2021_82840_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/2578f8f7b917/41598_2021_82840_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/2b383c3d4d6d/41598_2021_82840_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce57/7876037/5368d63773a9/41598_2021_82840_Fig6_HTML.jpg

相似文献

1
Predictive modeling of clinical trial terminations using feature engineering and embedding learning.使用特征工程和嵌入学习对临床试验终止进行预测建模。
Sci Rep. 2021 Feb 10;11(1):3446. doi: 10.1038/s41598-021-82840-x.
2
Understanding and predicting COVID-19 clinical trial completion vs. cessation.理解和预测 COVID-19 临床试验的完成与终止。
PLoS One. 2021 Jul 12;16(7):e0253789. doi: 10.1371/journal.pone.0253789. eCollection 2021.
3
Improving clinical trial design using interpretable machine learning based prediction of early trial termination.利用基于可解释机器学习的早期试验终止预测来改进临床试验设计。
Sci Rep. 2023 Jan 4;13(1):121. doi: 10.1038/s41598-023-27416-7.
4
Analysis of Terminated Hand and Wrist-Related Clinical Trials.终止的手部和腕部相关临床试验分析。
J Hand Surg Glob Online. 2023 May 10;5(5):673-676. doi: 10.1016/j.jhsg.2023.04.003. eCollection 2023 Sep.
5
CNFE-SE: a novel approach combining complex network-based feature engineering and stacked ensemble to predict the success of intrauterine insemination and ranking the features.CNFE-SE:一种结合基于复杂网络的特征工程和堆叠集成的新方法,用于预测宫腔内人工授精的成功率和对特征进行排序。
BMC Med Inform Decis Mak. 2021 Jan 2;21(1):1. doi: 10.1186/s12911-020-01362-0.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Latent Dirichlet Allocation in predicting clinical trial terminations.潜在狄利克雷分配在预测临床试验终止中的应用。
BMC Med Inform Decis Mak. 2019 Nov 27;19(1):242. doi: 10.1186/s12911-019-0973-y.
8
Exploring investor-business-market interplay for business success prediction.探索投资者-企业-市场的相互作用以预测企业成功。
J Big Data. 2023;10(1):48. doi: 10.1186/s40537-023-00723-6. Epub 2023 Apr 16.
9
Accurate Prediction of Coronary Heart Disease for Patients With Hypertension From Electronic Health Records With Big Data and Machine-Learning Methods: Model Development and Performance Evaluation.利用大数据和机器学习方法从电子健康记录中准确预测高血压患者的冠心病:模型开发与性能评估
JMIR Med Inform. 2020 Jul 6;8(7):e17257. doi: 10.2196/17257.
10
Predicting hospitalization following psychiatric crisis care using machine learning.运用机器学习预测精神科危机护理后的住院情况。
BMC Med Inform Decis Mak. 2020 Dec 10;20(1):332. doi: 10.1186/s12911-020-01361-1.

引用本文的文献

1
A scoping review of artificial intelligence applications in clinical trial risk assessment.人工智能在临床试验风险评估中的应用范围综述。
NPJ Digit Med. 2025 Jul 30;8(1):486. doi: 10.1038/s41746-025-01886-7.
2
Predicting accrual success for better clinical trial resource allocation.预测入组成功率以优化临床试验资源分配。
Sci Rep. 2025 Jan 31;15(1):3879. doi: 10.1038/s41598-025-88400-x.
3
A Novel Model Using ML Techniques for Clinical Trial Design and Expedited Patient Onboarding Process.一种使用机器学习技术进行临床试验设计和加速患者入组流程的新型模型。

本文引用的文献

1
Latent Dirichlet Allocation in predicting clinical trial terminations.潜在狄利克雷分配在预测临床试验终止中的应用。
BMC Med Inform Decis Mak. 2019 Nov 27;19(1):242. doi: 10.1186/s12911-019-0973-y.
2
Mycosis Fungoides and Sézary Syndrome: An Update.蕈样肉芽肿和赛泽里综合征:最新进展。
Hematol Oncol Clin North Am. 2019 Feb;33(1):103-120. doi: 10.1016/j.hoc.2018.09.001.
3
Modern Challenges of Cancer Clinical Trials.癌症临床试验的现代挑战
Clinicoecon Outcomes Res. 2025 Jan 16;17:1-18. doi: 10.2147/CEOR.S479603. eCollection 2025.
4
The Artificial Intelligence-Powered New Era in Pharmaceutical Research and Development: A Review.人工智能驱动的药物研发新时代:综述。
AAPS PharmSciTech. 2024 Aug 15;25(6):188. doi: 10.1208/s12249-024-02901-y.
5
A scoping review of machine learning for sepsis prediction- feature engineering strategies and model performance: a step towards explainability.基于机器学习的脓毒症预测的范围综述——特征工程策略和模型性能:迈向可解释性的一步。
Crit Care. 2024 May 28;28(1):180. doi: 10.1186/s13054-024-04948-6.
6
The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives.人工智能/机器学习在药物发现、开发、临床测试和制造中的崭露头角:FDA 的观点。
Drug Des Devel Ther. 2023 Sep 6;17:2691-2725. doi: 10.2147/DDDT.S424991. eCollection 2023.
7
New drugs and stock market: a machine learning framework for predicting pharma market reaction to clinical trial announcements.新药和股票市场:预测制药市场对临床试验公告反应的机器学习框架。
Sci Rep. 2023 Aug 7;13(1):12817. doi: 10.1038/s41598-023-39301-4.
8
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design.制药技术与药物递送设计中的人工智能
Pharmaceutics. 2023 Jul 10;15(7):1916. doi: 10.3390/pharmaceutics15071916.
9
Deep learning-based risk prediction for interventional clinical trials based on protocol design: A retrospective study.基于方案设计的深度学习在介入性临床试验中的风险预测:一项回顾性研究。
Patterns (N Y). 2023 Feb 10;4(3):100689. doi: 10.1016/j.patter.2023.100689. eCollection 2023 Mar 10.
10
Predicting Publication of Clinical Trials Using Structured and Unstructured Data: Model Development and Validation Study.利用结构化和非结构化数据预测临床试验发表:模型开发和验证研究。
J Med Internet Res. 2022 Dec 23;24(12):e38859. doi: 10.2196/38859.
Clin Oncol (R Coll Radiol). 2017 Dec;29(12):767-769. doi: 10.1016/j.clon.2017.10.006. Epub 2017 Oct 21.
4
Statistical issues associated with terminating a clinical trial due to slow enrollment.与因入组缓慢而终止临床试验相关的统计学问题。
J Nucl Cardiol. 2017 Apr;24(2):525-526. doi: 10.1007/s12350-016-0702-1. Epub 2016 Nov 1.
5
A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials.基于数据驱动的临床试验成败预测方法。
Cell Chem Biol. 2016 Oct 20;23(10):1294-1301. doi: 10.1016/j.chembiol.2016.07.023. Epub 2016 Sep 15.
6
Key cost drivers of pharmaceutical clinical trials in the United States.美国药物临床试验的关键成本驱动因素。
Clin Trials. 2016 Apr;13(2):117-26. doi: 10.1177/1740774515625964. Epub 2016 Feb 8.
7
Trends in National Institutes of Health Funding for Clinical Trials Registered in ClinicalTrials.gov.美国国立卫生研究院对在ClinicalTrials.gov上注册的临床试验的资助趋势。
JAMA. 2015 Dec 15;314(23):2566-7. doi: 10.1001/jama.2015.12206.
8
Registration practices for observational studies on ClinicalTrials.gov indicated low adherence.ClinicalTrials.gov 上观察性研究的注册实践表明,其遵循度较低。
J Clin Epidemiol. 2016 Feb;70:176-82. doi: 10.1016/j.jclinepi.2015.09.009. Epub 2015 Sep 18.
9
Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination.ClinicalTrials.gov结果数据库中的终止试验:主要结局数据可用性及终止原因评估
PLoS One. 2015 May 26;10(5):e0127242. doi: 10.1371/journal.pone.0127242. eCollection 2015.
10
Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials.试验招募失败与人体受试者保护:对近期结束试验的实证分析
Clin Trials. 2015 Feb;12(1):77-83. doi: 10.1177/1740774514558307. Epub 2014 Dec 4.